AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding AC Immune SA changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 40 | 42 | +2 |
| Shares | 24.6M | 25.9M | +1.25M (+5.1%) |
| Value | $71.1M | $81.2M | +$10.1M (+14.2%) |
New holders (8)
Institutions that held AC Immune SA at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 384,845 | $1.21M | 0.00% |
| Arrowstreet Capital, Limited Partnership | 375,623 | $1.18M | 0.00% |
| Marshall Wace, LLP | 186,709 | $586.3K | 0.00% |
| Dauntless Investment Group, LLC | 115,677 | $363.2K | 1.34% |
| Deeter Investments LLP | 100,000 | $314.0K | 0.07% |
| EFG International AG | 12,900 | $40.5K | 0.00% |
| Jane Street Group, LLC | 10,710 | $33.6K | 0.00% |
| Leonteq Securities AG | 3,000 | $9.42K | 0.00% |
Sold out (6)
Institutions that held AC Immune SA at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Deutsche Bank AG | 253,375 | $732.3K |
| Assenagon Asset Management S.A. | 189,892 | $548.8K |
| Two Sigma Advisers, LP | 20,938 | $60.5K |
| Private Advisor Group, LLC | 16,600 | $48.0K |
| State of Tennessee, Treasury Department | 5,126 | $14.8K |
| Simplex Trading, LLC | 3,258 | $9.00K |